Clinical Trials Browser

Phase 2 × Adenolymphoma × Fluorescein × Clear all

NCT06054178 2025-07-28

Identification of Nerves Using Fluorescein Sodium

Phase 2 Enrolling by invitation

Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases